Despite the significant advances in the diagnosis and treatments, Cardiovascular disease (CVD) still represents the leading cause of morbidity and mortality worldwide. The introduction of artificial intelligence (AI) has the potential to cardiovascular disease management and care. On Wednesday, 18 November at 12.15, within the framework of the My City-Lab project – an ambitious project financed by the European Regional Development Fund (ERDF) to improve ambulatory care of chronic patients through innovative diagnostic solutions and digital tools – this workshop will identify and discuss systematic changes to improve and optimise CDV outcomes through AI.
This debate will highlight how AI can support the screening and therefore prevention of cardiovascular diseases by exploring what are the benefits it can offer to patients, what are the main barriers AI encounters on its application and what might be the risks of its implementation for patients. Additionally, the speakers will discuss how EU countries could boost the implementation of AI in healthcare systems for CVD care and what are the strategies already in place for screening CVD by means of AI to ensure the quality of care and patient safety.
The expert line-up for this session include Maria Carvalho, MEP and Co-Chair of the MEP Heart Group; Prof. Alan Fraser, European Society of Cardiology; Birgit Beger, European Heart Network; Ed Harding, The Heart Failure Policy Network; and Dr. Erik R. Ranschaert, ETZ hospital. The workshop will be moderated by Prof. Damien Gruson, My City-Lab; Saint Luc Hospital; and Member of the Expert Panel on Effective Ways of Investing in Health of the European Commission.
Join EHMA 2020, the preeminent European conference on health management, and join our community of practice, where you can debate and identify solutions for the most current topics in health management.